Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh (WATC34) Stock Price & Analysis

WATC34 Stock Chart & Stats

R$0.01-R$476.57(-100.00%)

At close: Oct 30

Day’s Range: BRL 0.01 - BRL 633.75
52-Week Range: BRL 0.01 - BRL 633.75
Previous Close: BRL 476.58
Volume: N/A
Average Volume (3M): 0
Market Cap: BRL 247.17B
Enterprise Value: BRL 212.65B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 1.8
Beta: 2.10
Next Earnings: Nov 03, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh News

Waters, Labcorp partner to expand access to cervical cancer screening

Labcorp (LH) and Waters (WAT) announced a partnership to expand access to the FDA-approved BD Onclarity HPV Assay through Labcorp’s nationwide laboratory network beginning in late 2026. Cervical cancer is

1w agoLH WAT

Waters, Labcorp partner to expand access to cervical screening

1w agoLH WAT

Waters price target raised to $515 from $475 at TD Cowen

TD Cowen raised the firm’s price target on Waters (WAT) to $515 from $475 and keeps a Buy rating on the shares. The firm adjusted targets in the life science

2w agoWAT WAZ

Waters price target raised to $465 from $430 at BofA

BofA analyst Avantika Dhabaria raised the firm’s price target on Waters (WAT) to $465 from $430 and keeps a Neutral rating on the shares. The life science tools sector has

3w agoWAT WAZ

Waters price target raised to $500 from $460 at Barclays

Barclays raised the firm’s price target on Waters (WAT) to $500 from $460 and keeps an Overweight rating on the shares. The firm adjusted targets in the life science and

3w agoWAT WAZ

Waters price target raised to $490 from $440 at Guggenheim

Guggenheim analyst Subbu Nambi raised the firm’s price target on Waters (WAT) to $490 from $440 and keeps a Buy rating on the shares. The firm adjusted its models and

1M agoWAT WAZ

White House moves to take control of N.I.H. grants, NY Times reports

The White House has begun drafting a new executive order that could further cement President Trump’s ability to control billions of dollars in scientific grants and expand the administration’s pressure

1M agoA DHR

Waters price target raised to $515 from $465 at Goldman Sachs

Goldman Sachs analyst Evie Koslosky raised the firm’s price target on Waters (WAT) to $515 from $465 and keeps a Buy rating on the shares. Published first on TheFly –

1M agoWAT WAZ

Waters Corp: Multi‑Year Growth Drivers Seen as Priced In, Risk‑Reward Balanced with Price Target Maintained at $430 and Hold Rating Reiterated

Waters, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kallum Titchmarsh from Morgan Stanley maintained a Hold rating on the stock and has a $430.00

1M agoWAT WAZ

Waters assumed with a Buy at UBS

UBS analyst Doug Schenkel assumed coverage of Waters (WAT) with a Buy rating and $490 price target The market may still be underappreciating the value creation from Waters’ BD Life

1M agoWAT WAZ

Piper upgrades Waters to Overweight on replacement cycle

Piper Sandler upgraded Waters (WAT) to Overweight from Neutral with a price target of $480, up from $400. The firm cites the “strong” replacement cycle and its work in flow

2M agoWAT WAZ

Waters Upgraded to Buy as Durable Growth Profile and BDX Synergies Drive Price Target Increase to $475

Waters, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Daniel Brennan from TD Cowen upgraded the rating on the stock to a Buy and gave

2M agoWAT WAZ

Analyst Maintains Buy on Waters as Broad-Based End-Market Recovery and Synergies Bolster Growth Outlook

William Blair analyst Matt Larew has maintained their bullish stance on WAT stock, giving a Buy rating on July 22. Matt Larew has given his Buy rating due to a

3M agoWAT WAZ

Waters Corp: Advanced Diagnostics Strength Drives Guidance Raise and Price Target Increase to $415, But Valuation Keeps Rating at Hold

Bank of America Securities analyst Michael Ryskin maintained a Hold rating on Waters today and set a price target of $415.00. Michael Ryskin has given his Hold rating due to

3M agoWAT WAZ

WATC34 FAQ

What was Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh’s price range in the past 12 months?

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh lowest stock price was R$0.01 and its highest was R$633.75 in the past 12 months.

What is Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh’s market cap?

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh’s market cap is R$247.17B.

When is Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh’s earnings last quarter?

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh released its earnings results on Aug 04, 2026. The company reported -R$0.002 earnings per share for the quarter.

Is Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh pay dividends?

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh does not currently pay dividends.

What is Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh’s EPS estimate?

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh have?

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh has 98,248,110 shares outstanding.

What happened to Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh’s price movement after its last earnings report?

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh reported an EPS of -R$0.002 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh?

Currently, no hedge funds are holding shares in BR:WATC34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh (WATC34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Bearish
Overall Consensus	5	14
Technical Analysis	5	2
Moving Averages	0	12

Technical Analysis >

Similar Stocks

Stocks similar to BR:WATC34
Company	Price & Change	Follow
BR:A1GI34Agilent Technologies, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh
BR:GEHC34GE Healthcare Technologies Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh
BR:I1DX34IDEXX Laboratories, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
BR:I1LM34Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
BR:R1OP34Roper Technologies, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh

Compare BR:WATC34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

WATC34 Stock Chart & Stats

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh News

Waters, Labcorp partner to expand access to cervical cancer screening

Waters, Labcorp partner to expand access to cervical screening

Waters price target raised to $515 from $475 at TD Cowen

Waters price target raised to $465 from $430 at BofA

Waters price target raised to $500 from $460 at Barclays

Waters price target raised to $490 from $440 at Guggenheim

White House moves to take control of N.I.H. grants, NY Times reports

Waters price target raised to $515 from $465 at Goldman Sachs

Waters Corp: Multi‑Year Growth Drivers Seen as Priced In, Risk‑Reward Balanced with Price Target Maintained at $430 and Hold Rating Reiterated

Waters assumed with a Buy at UBS

Piper upgrades Waters to Overweight on replacement cycle

Waters Upgraded to Buy as Durable Growth Profile and BDX Synergies Drive Price Target Increase to $475

Analyst Maintains Buy on Waters as Broad-Based End-Market Recovery and Synergies Bolster Growth Outlook

Waters Corp: Advanced Diagnostics Strength Drives Guidance Raise and Price Target Increase to $415, But Valuation Keeps Rating at Hold

WATC34 FAQ

Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh (WATC34) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium